KFDA approves Argenxs Vibgart for severe myasthenia gravis treatment KFDA greenlights innovative therapy for muscle weakness ...
Hosted on MSN23h
New discovery revolutionizes treatment of autoimmune disordersA breakthrough discovery in enzyme science could revolutionize the treatment of autoimmune disorders and other diseases tied ...
CeRMS (Center for Research and Medical Studies), A.O. Città della Salute e della Scienza di Torino, Torino, Italy. Department of Orthopaedics, A.O. Città della Salute e della Scienza di Torino, Torino ...
Epidermal growth factor receptor (EGFR) is a major driver of cancer dissemination and target for anti-cancer therapies but ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...
After hours: January 22 at 4:02:06 PM EST ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback